0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-32I2193
Home | Market Reports | Health| Nursing
Global At Home Drug of Abuse DOA Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global At-Home Drug of Abuse (DOA) Testing Market Research Report 2024

Code: QYRE-Auto-32I2193
Report
March 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

At-Home Drug of Abuse (DOA) Testing Market Size

The global At-Home Drug of Abuse (DOA) Testing market was valued at US$ 413.2 million in 2023 and is anticipated to reach US$ 862.3 million by 2030, witnessing a CAGR of 10.6% during the forecast period 2024-2030.

At-Home Drug of Abuse (DOA) Testing Market

At-Home Drug of Abuse (DOA) Testing Market

The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
This report aims to provide a comprehensive presentation of the global market for At-Home Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding At-Home Drug of Abuse (DOA) Testing.

Report Scope

The At-Home Drug of Abuse (DOA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global At-Home Drug of Abuse (DOA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the At-Home Drug of Abuse (DOA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of At-Home Drug of Abuse (DOA) Testing Market Report

Report Metric Details
Report Name At-Home Drug of Abuse (DOA) Testing Market
Accounted market size in 2023 US$ 413.2 million
Forecasted market size in 2030 US$ 862.3 million
CAGR 10.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Test Cups
  • Test Dip Cards
  • Test Strips
  • Others
Segment by Application
  • Urine
  • Saliva
  • Hair
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of At-Home Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is At-Home Drug of Abuse (DOA) Testing Market growing?

Ans: The At-Home Drug of Abuse (DOA) Testing Market witnessing a CAGR of 10.6% during the forecast period 2024-2030.

What is the At-Home Drug of Abuse (DOA) Testing Market size in 2030?

Ans: The At-Home Drug of Abuse (DOA) Testing Market size in 2030 will be US$ 862.3 million.

Who are the main players in the At-Home Drug of Abuse (DOA) Testing Market report?

Ans: The main players in the At-Home Drug of Abuse (DOA) Testing Market are UCP Biosciences, Orient New Life Medical, Express Diagnostics Int’l, Assure Tech (Hangzhou), Psychemedics Corporation, Confirm BioSciences, Phamatech, Home Health (U.K.) Ltd., Quest Products

What are the Application segmentation covered in the At-Home Drug of Abuse (DOA) Testing Market report?

Ans: The Applications covered in the At-Home Drug of Abuse (DOA) Testing Market report are Urine, Saliva, Hair, Others

What are the Type segmentation covered in the At-Home Drug of Abuse (DOA) Testing Market report?

Ans: The Types covered in the At-Home Drug of Abuse (DOA) Testing Market report are Test Cups, Test Dip Cards, Test Strips, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Test Cups
1.2.3 Test Dip Cards
1.2.4 Test Strips
1.2.5 Others
1.3 Market by Application
1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Urine
1.3.3 Saliva
1.3.4 Hair
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2019-2030)
2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Size by Region (2019-2024)
2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030)
2.3 At-Home Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 At-Home Drug of Abuse (DOA) Testing Industry Trends
2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2019-2024)
3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2023
3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2019-2024)
4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030)
5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2019-2024)
5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2019-2030)
6.2 North America At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2019-2030)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2019-2030)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2019-2030)
9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2019-2030)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UCP Biosciences
11.1.1 UCP Biosciences Company Detail
11.1.2 UCP Biosciences Business Overview
11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.1.5 UCP Biosciences Recent Development
11.2 Orient New Life Medical
11.2.1 Orient New Life Medical Company Detail
11.2.2 Orient New Life Medical Business Overview
11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.2.5 Orient New Life Medical Recent Development
11.3 Express Diagnostics Int’l
11.3.1 Express Diagnostics Int’l Company Detail
11.3.2 Express Diagnostics Int’l Business Overview
11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.3.5 Express Diagnostics Int’l Recent Development
11.4 Assure Tech (Hangzhou)
11.4.1 Assure Tech (Hangzhou) Company Detail
11.4.2 Assure Tech (Hangzhou) Business Overview
11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.4.5 Assure Tech (Hangzhou) Recent Development
11.5 Psychemedics Corporation
11.5.1 Psychemedics Corporation Company Detail
11.5.2 Psychemedics Corporation Business Overview
11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.5.5 Psychemedics Corporation Recent Development
11.6 Confirm BioSciences
11.6.1 Confirm BioSciences Company Detail
11.6.2 Confirm BioSciences Business Overview
11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.6.5 Confirm BioSciences Recent Development
11.7 Phamatech
11.7.1 Phamatech Company Detail
11.7.2 Phamatech Business Overview
11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.7.5 Phamatech Recent Development
11.8 Home Health (U.K.) Ltd.
11.8.1 Home Health (U.K.) Ltd. Company Detail
11.8.2 Home Health (U.K.) Ltd. Business Overview
11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.8.5 Home Health (U.K.) Ltd. Recent Development
11.9 Quest Products
11.9.1 Quest Products Company Detail
11.9.2 Quest Products Business Overview
11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
11.9.5 Quest Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Test Cups
    Table 3. Key Players of Test Dip Cards
    Table 4. Key Players of Test Strips
    Table 5. Key Players of Others
    Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2019-2024)
    Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region (2025-2030)
    Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends
    Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers
    Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges
    Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints
    Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players (2019-2024)
    Table 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2023)
    Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
    Table 23. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2019-2024)
    Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2025-2030)
    Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2019-2024)
    Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2025-2030)
    Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 48. UCP Biosciences Company Detail
    Table 49. UCP Biosciences Business Overview
    Table 50. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product
    Table 51. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 52. UCP Biosciences Recent Development
    Table 53. Orient New Life Medical Company Detail
    Table 54. Orient New Life Medical Business Overview
    Table 55. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product
    Table 56. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 57. Orient New Life Medical Recent Development
    Table 58. Express Diagnostics Int’l Company Detail
    Table 59. Express Diagnostics Int’l Business Overview
    Table 60. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product
    Table 61. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 62. Express Diagnostics Int’l Recent Development
    Table 63. Assure Tech (Hangzhou) Company Detail
    Table 64. Assure Tech (Hangzhou) Business Overview
    Table 65. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product
    Table 66. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 67. Assure Tech (Hangzhou) Recent Development
    Table 68. Psychemedics Corporation Company Detail
    Table 69. Psychemedics Corporation Business Overview
    Table 70. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product
    Table 71. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 72. Psychemedics Corporation Recent Development
    Table 73. Confirm BioSciences Company Detail
    Table 74. Confirm BioSciences Business Overview
    Table 75. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product
    Table 76. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 77. Confirm BioSciences Recent Development
    Table 78. Phamatech Company Detail
    Table 79. Phamatech Business Overview
    Table 80. Phamatech At-Home Drug of Abuse (DOA) Testing Product
    Table 81. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 82. Phamatech Recent Development
    Table 83. Home Health (U.K.) Ltd. Company Detail
    Table 84. Home Health (U.K.) Ltd. Business Overview
    Table 85. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product
    Table 86. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 87. Home Health (U.K.) Ltd. Recent Development
    Table 88. Quest Products Company Detail
    Table 89. Quest Products Business Overview
    Table 90. Quest Products At-Home Drug of Abuse (DOA) Testing Product
    Table 91. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
    Table 92. Quest Products Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2023 VS 2030
    Figure 3. Test Cups Features
    Figure 4. Test Dip Cards Features
    Figure 5. Test Strips Features
    Figure 6. Others Features
    Figure 7. Global At-Home Drug of Abuse (DOA) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2023 VS 2030
    Figure 9. Urine Case Studies
    Figure 10. Saliva Case Studies
    Figure 11. Hair Case Studies
    Figure 12. Others Case Studies
    Figure 13. At-Home Drug of Abuse (DOA) Testing Report Years Considered
    Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global At-Home Drug of Abuse (DOA) Testing Market Share by Region: 2023 VS 2030
    Figure 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2023
    Figure 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2023
    Figure 20. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
    Figure 22. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
    Figure 26. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Region (2019-2030)
    Figure 34. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
    Figure 42. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
    Figure 46. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 49. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 50. Express Diagnostics Int’l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 51. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 52. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 53. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 54. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 55. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 56. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2019-2024)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture